The following is an excerpt.
A promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) has been shown in cell culture and in animal models to selectively kill cancer stem cells at the original tumor site and in distant metastases with no toxic effects on healthy cells, including normal stem cells.
Read the full story here: Targeted Viral Therapy Destroys Breast Cancer Stem Cells in Preclinical Experiments
